Acorda Therapeutics Licenses Rights To Investigational Treatment For Spinal Cord Injury And Traumatic Brain Injury

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has licensed worldwide development and commercialization rights to a proprietary magnesium formulation from Medtronic, Inc. (NYSE: MDT), which will be referred to as AC105…